DoW, Peer Reviewed Cancer, Impact Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- May 6, 2026
- Amount
- Program total $45M
- Closes
- Oct 5, 2026 (in 17 days)
Similar opportunities open now
- DoW Peer Reviewed Cancer, Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 17 days
- DoW Peer Reviewed Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 17 days
- DoW Peer Reviewed Medical, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 4 days
- DoW Peer Reviewed Medical, Platform Clinical Translation AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 4 days
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 13 days
Classification and identifiers
- Solicitation number
- HT942526PRCRPIPA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $45M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Impact Award supports mature research that will have a near-term impact on clinical cancer care in one of the congressionally directed FY26 PRCRP Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the Military Health System (MHS). Distinctive Features: • Applications must include preliminary data to support feasibility of the study. • Projects must have strong potential to result in a near-term impact in cancer. • The funding mechanism allows clinical trials. • This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the P...